HkeyBiospecializesinpreclinicalstudiesfordrugdiscovery.Exploreourcutting-edgeresearchinautoimmunediseasesandinnovativeanimalmodels.

更新时间：2025-07-13 直链：hkeybio.com

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

更新时间：2025-07-11 直链：westvacpharma.com

Nationalhigh-techbiotechnologyenterpriseintegratingR&D,production,thefounderteamofthecompanycomesfromfamousuniversitiesathomeandabroad.

更新时间：2025-07-03 直链：en.genfine.com

BiomedicalandEnvironmentalSciences(BES)isapeer-reviewedcomprehensivemedicaljournalsponsoredbytheChineseCenterforDiseaseControlandPrevention.

更新时间：2025-07-02 直链：besjournal.com

BeijingDCNOrthopaedicHospital,theauthorityofBeijingOrthopaedicHospital,hasateamofseniororthopaedicexpertsandanorthopaedicrehabilitationcenterwithadvancedequipment.ItisaprivateorthopaedichospitaldesignatedbytheathletesofthenationalteamoftheChineseOlympicCommittee.Itspecializesinglutealmusclecontracture,gout,femoralheadnecrosis,lumbardischerniation,cervicalspondylosis,lowerlimborthopedics,etc.Orthopedichospitalhotline:010-52713366

更新时间：2025-06-23 直链：en.dcn.org.cn

HarbourBioMed(HBMHoldings)isaglobalbiopharmaceuticalcompanycommittedtother&dandcommercializationofnovelantibodytherapeuticsinoncologyandimmunologicaldiseases.

更新时间：2025-06-23 直链：www.harbourbiomed.com